pharma · Lymphoma
Sinobioway Cell Therapy
Sinobioway Cell Therapy Co.,
Sinobioway Cell Therapy patent portfolio — 0 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
CN HQ
NMPA registrant Type
Company details
- Status
- Public
- HQ
- CN
- Programs
- 1
- Drugs
- 8
- Patents
- 0
Sinobioway Cell Therapy patents
0 pharmaceutical patents indexed for Sinobioway Cell Therapy. 0 expire within 24 months.
Sinobioway Cell Therapy has 0 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
No patents matched
Frequently asked questions
How many patents does Sinobioway Cell Therapy have?
0 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Sinobioway Cell Therapy patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.